In the U.S., 12% of adults say they are currently using a GLP-1 drug, up from 6% who said the same in 2024, according to a KFF survey
[DOI] [PMC free article] [PubMed] [Google Scholar] 8.Pagani M., Barsotti N., Bertero A., Trakoshis S., Ulysse L., Locarno A., Miseviciute I., De Felice A., Canella C., Supekar K., et al
Additionally, several studies indicate that although most metabolic changes show common trends in both UC and CD, distinct patterns can also be identified: for example, alterations in the bile acid pool, such as differential shifts in primary versus secondary bile acids
If pregnant or breast
The SOCS1-mimicking peptide reduced lupus-like symptoms in mouse models, demonstrating the potential to regulate an immune response that runs on overdrive